Promedior
New class of pentraxin therapeutics to treat rare fibrotic diseases, including: idiopathic pulmonary fibrosis (IPF), myelofibrosis, and fibrovascular....
Get a Demo and See the Full Profile
Get a demo today to see profiles of Promedior plus 5904 other startups.
